178 related articles for article (PubMed ID: 3531945)
1. [The diagnosis of multiple myeloma].
Bartl R; Fateh-Moghadam A
Onkologie; 1986 Aug; 9(4):183-8, 190-5. PubMed ID: 3531945
[TBL] [Abstract][Full Text] [Related]
2. [Classification, staging and prognostic indices for multiple myeloma].
Hotta T
Nihon Rinsho; 2007 Dec; 65(12):2161-6. PubMed ID: 18069256
[TBL] [Abstract][Full Text] [Related]
3. Lymphoproliferative disorders in the bone marrow: histologic criteria for classification and staging.
Bartl R; Frisch B; Hoffmann-Fezer G; Burkhardt R
Haematologia (Budap); 1984; 17(2):227-46. PubMed ID: 6534830
[TBL] [Abstract][Full Text] [Related]
4. Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases.
Bartl R; Frisch B; Fateh-Moghadam A; Kettner G; Jaeger K; Sommerfeld W
Am J Clin Pathol; 1987 Mar; 87(3):342-55. PubMed ID: 3825999
[TBL] [Abstract][Full Text] [Related]
5. [Smoldering multiple myeloma].
Zapatero A; Blanco L; Sevilla F; Fraile G; Montalbán C
Rev Clin Esp; 1985 May; 176(9):469-70. PubMed ID: 4023335
[No Abstract] [Full Text] [Related]
6. [The diagnostic value of monoclonal proteins in serum].
Erikssen J; Lingjaerde P
Tidsskr Nor Laegeforen; 1973 Sep; 93(25):1733-6. PubMed ID: 4771905
[No Abstract] [Full Text] [Related]
7. Unusually prominent M protein in Indian patients with IgD multiple myeloma.
Inamdar NA; Parikh PM; Hedge RM; Karkhanis VC; Sastry PS; Gopal R; Raste AS; Advani SH
Acta Haematol; 1995; 94(4):216-7. PubMed ID: 8610482
[No Abstract] [Full Text] [Related]
8. Pathologic studies useful for the diagnosis and monitoring of plasma cell dyscrasias.
Veillon DM; Cotelingam JD
Contrib Nephrol; 2007; 153():25-43. PubMed ID: 17075222
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of a histologic classification system applied in bone marrow biopsies from patients with multiple myeloma: a histopathological evaluation of biopsies from 153 untreated patients.
Sailer M; Vykoupil KF; Peest D; Coldewey R; Deicher H; Georgii A
Eur J Haematol; 1995 Mar; 54(3):137-46. PubMed ID: 7720832
[TBL] [Abstract][Full Text] [Related]
10. Tumor distribution classification system for multiple myeloma: clinical features and prognosis.
Sezaki T; Izumi K; Hoshijima T; Adachi T; Takahashi I; Kimura I
Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1784-91. PubMed ID: 3564859
[No Abstract] [Full Text] [Related]
11. Clinical significance of bone marrow biopsy and plasma cell morphology in MM and MGUS.
Bartl R; Frisch B
Pathol Biol (Paris); 1999 Feb; 47(2):158-68. PubMed ID: 10192882
[TBL] [Abstract][Full Text] [Related]
12. Suppression of polyclonal immunoglobulins in multiple myeloma: relationship to the staging and other manifestations at diagnosis.
Pruzanski W; Gidon MS; Roy A
Clin Immunol Immunopathol; 1980 Oct; 17(2):280-6. PubMed ID: 7408241
[No Abstract] [Full Text] [Related]
13. [Prognostic clinical and morphological classification of multiple myeloma (author's transl)].
Wutke K; Rüdiger KD; Kelényi G
Arch Geschwulstforsch; 1979; 49(8):671-84. PubMed ID: 543783
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic criteria of multiple myeloma.
Kyle RA
Hematol Oncol Clin North Am; 1992 Apr; 6(2):347-58. PubMed ID: 1582977
[TBL] [Abstract][Full Text] [Related]
15. [The CBO professional guideline 'monoclonal gammopathy' (paraproteinemia) (revision)].
Buiting AM; Wijermans PW
Ned Tijdschr Geneeskd; 2002 Jul; 146(30):1406-11. PubMed ID: 12174434
[TBL] [Abstract][Full Text] [Related]
16. [The percentage of bone marrow plasmacytes and prognosis in multiple myeloma].
Paule B; Quillard J; Bennet P; Bisson M; Massias P
Rev Rhum Mal Osteoartic; 1988 Dec; 55(12):969-72. PubMed ID: 3238308
[TBL] [Abstract][Full Text] [Related]
17. Classification and prognostic evaluation in multiple myeloma. A retrospective study of relationship of survivals and responses to chemotherapy to immunological types, 20 single prognostic factors, 15 clinical staging systems, and 6 morphological classifications.
Pasqualetti P; Colantonio D; Collacciani A; Casale R; Natali G
Panminerva Med; 1991; 33(2):93-110. PubMed ID: 1923560
[TBL] [Abstract][Full Text] [Related]
18. [Comparative study of 2 prognostic classification systems for myeloma and examination of the correlation between initial bone marrow plasmacytosis and prognosis. A propos of a homogeneous population of 50 patients followed from diagnosis to death].
Pesce A; Cassuto JP; Grisot C; Gratecos N; Bayle J; Viot G; Dujardin P
Nouv Rev Fr Hematol (1978); 1983; 25(5):311-7. PubMed ID: 6657481
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis.
Dinner S; Witteles W; Witteles R; Lam A; Arai S; Lafayette R; George TI; Schrier SL; Liedtke M
Br J Haematol; 2013 May; 161(3):367-72. PubMed ID: 23432783
[TBL] [Abstract][Full Text] [Related]
20. [Clinical aspects of multiple myeloma].
López Alvarez J; Sanz Marca A; Aboin Massieu FJ
Rev Clin Esp; 1983 Nov; 171(3):165-74. PubMed ID: 6366936
[No Abstract] [Full Text] [Related]
[Next] [New Search]
